AI Science Tracker

University of Pennsylvania

5 discoveries from 2023 to 2026

Discoveries

Deep learning identifies antimicrobial peptides hidden in prion-related proteins

APEX 1.1 screened 19.3 million peptide fragments from 2,897 prion-related proteins and identified 1,179 candidate antimicrobial peptides, termed prionins. Among 75 synthesized candidates, 59 inhibited at least one tested bacterial strain; two selected peptides reduced Acinetobacter baumannii burden in a mouse skin-abscess model. The study shows that prion-related sequences can yield experimentally active antimicrobial fragments, but does not show that these peptides are naturally released or function as host-defense agents in their source organisms.

Technology: APEX 1.1 deep-learning antimicrobial-peptide prediction and prioritization

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Of 75 synthesized APEX-selected prionins, 59 inhibited at least one bacterial strain in vitro; two selected peptides reduced A. baumannii burden in a mouse skin-abscess model.
  • Still unknown: No evidence shows these fragments are naturally released from their source proteins or physiologically function as host-defense peptides in native organisms. Mouse results do not establish human efficacy or safety.
  • AI role: APEX 1.1 scored peptide fragments for predicted antimicrobial activity and prioritized candidates from a search across prion-related proteins for synthesis and experimental screening.

Evidence sources: https://www.nature.com/articles/s41564-026-02408-1

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 17 Nov 2026. Review scope: Primary Nature Microbiology full text as indexed, including methods, results, author contributions and affiliations..

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Deep learning mines venom proteomes for antimicrobial peptides active in vitro and in a mouse infection model

The APEX deep-learning model screened 16,123 venom proteins by generating and scoring 40,626,260 venom-encrypted peptides. After activity prediction and filtering for low similarity to known antimicrobial peptides, the authors selected 58 for experiments; 53 showed antimicrobial activity against at least one tested pathogen. Three selected peptides reduced bacterial counts after topical treatment in a mouse Acinetobacter baumannii skin-abscess model; the wolf-spider-derived Arachnoserver-5 peptide produced a reported three-log reduction versus untreated controls through day four, without significant body-weight change under the study conditions.

Technology: APEX deep-learning model for bacterial strain-specific minimum inhibitory concentration prediction

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: After activity prediction and filtering for low similarity to known antimicrobial peptides, the authors selected 58 for experiments; 53 showed antimicrobial activity against at least one tested pathogen.
  • Still unknown: Only 58 of the 386 low-similarity candidates were experimentally tested, and activity was measured against a defined panel of 11 strains; some tested peptides were cytotoxic. The mouse study was a topical single-dose skin-abscess model with six animals per group, not systemic treatment or human efficacy. The paper notes possible ion-channel activity for many candidates and calls for follow-up safety testing. A related APEX study mined archaeal proteomes (10.1038/s41564-025-02061-0); this entry is limited to the separate venom-protein source library and its distinct peptide set and experiments.
  • AI role: APEX scored 40.6 million candidate peptide fragments generated from venom proteins for predicted antimicrobial activity. The authors filtered predicted hits for sequence dissimilarity to known antimicrobial peptides, synthesized a selected subset, and experimentally tested antimicrobial activity, cytotoxicity and selected animal-model efficacy. The AI model narrowed an otherwise very large peptide search space; assays established which selected candidates were active.

Evidence sources: https://www.nature.com/articles/s41467-025-60051-6.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 61 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

ApexGO optimizes antimicrobial peptide activity

ApexGO uses Bayesian optimization with a peptide variational autoencoder and an activity-prediction oracle to optimize derivatives of ten peptide templates. The primary article reports 100 synthesized sequences tested in vitro and activity improvements; selected candidates showed activity in mouse A. baumannii infection models. These results are preclinical and do not establish human efficacy.

Technology: ApexGO; peptide variational autoencoder; Bayesian optimization; APEX predictor

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The primary source reports the study-specific result summarized here.
  • Still unknown: Independent replication and broad deployment are not established by this review.
  • AI role: A predictor scores generated peptide derivatives and Bayesian optimization uses feedback to propose variants; researchers synthesize and test them in vitro and in mouse models.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13201158/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: Primary-source indexed article or abstract and bibliographic metadata reviewed; complete source scope is given in source_checks..

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

AMPSphere: antimicrobial peptides from the global microbiome

Machine learning identified 863,498 candidate sequences in microbial genomes and metagenomes. Of 100 synthesized peptides, 63 inhibited at least one of the eleven strains tested; some showed activity in animal models. The catalog contains candidates, not hundreds of thousands of clinically validated antibiotics.

Technology: Machine learning for antimicrobial peptides

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: 100 predicted peptides were synthesized and tested in vitro and in vivo against drug-resistant pathogens and human gut commensals; 63 inhibited pathogens.
  • Still unknown: The abstract states no limitations and does not name the strains or animal models used.
  • AI role: Machine learning predicted antimicrobial peptides across 63,410 metagenomes and 87,920 genomes, producing a catalog of 863,498 non-redundant candidates.

Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1016/j.cell.2024.05.013&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 477 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Neanderthal and Denisovan peptides reconstructed as antibiotic candidates

AI analysis of proteins from extinct hominins identified sequences that were then synthesized and tested against pathogens in culture and in mice. Some peptides showed antimicrobial activity; these are preclinical results, with no demonstration of safety or efficacy in humans.

Technology: AI for molecular de-extinction

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Fragments were tested for antimicrobial activity in vitro, and representative fragments reduced A. baumannii infection in mouse skin abscess and thigh infection models.
  • Still unknown: The abstract does not explicitly state limitations; the findings rest on in vitro work and two mouse models rather than human trials.
  • AI role: A random forest model (panCleave) predicted protease cleavage sites across proteomes to find antimicrobial fragments in modern human and extinct hominin proteins.

Evidence sources: https://www.engineering.upenn.edu/stories/for-a-new-generation-of-antibiotics-scientists-are-bringing-extinct-molecules-back-to-life-and-discovering-the-hidden-genetics-of-immunity-along-the-way/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1016/j.chom.2023.07.001&resultType=core&format=json

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 165 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.